Evidence map›Paper›PMID 37738881›Full record

ArticleAmerican journal of otolaryngology

Chemosensory function recovery in COVID-19 patients: A cross-sectional study.

Aria Nawab, Aura Acosta, Corinna G Levine, Michael E Hoffer, Roy Casiano, Xue Zhong Liu

Abstract read
In one paragraph

Article in American journal of otolaryngology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aria NawabDepartment of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, United States of America.
Aura AcostaDepartment of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, United States of America.
Corinna G LevineDepartment of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, United States of America.
Michael E HofferDepartment of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, United States of America; Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL, United States of America.
Roy CasianoDepartment of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, United States of America.
Xue Zhong LiuDepartment of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, United States of America. Electronic address: x.liu1@med.miami.edu.

Funding

Molecular Genetics on Non Syndromic Hearing Loss (NSHL)R01DC005575 · NIDCD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LIU, XUE Z · 2001 to 2024
$10.6M
Sensory disorders in COVID -19 as an early identifier and healthcare worker protectionR01DC012115 · NIDCD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LIU, XUE Z · 2013 to 2022
$7.2M
Eosinophilic Mucin Chronic Rhinosinusitis: Determining the multi-level factors that mediate disease and disparitiesK23MD018458 · NIMHD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CORINNA GEHRETT LEVINE · 2023 to 2026
$618k
NIDCD NIH HHS L30 DC017313NIDCD NIH HHS R01 DC005575NIDCD NIH HHS R01 DC012115NIMHD NIH HHS K23 MD018458
6 · The paper itself

Abstract

objectiveTo determine whether subjects who have recovered from COVID-19 smell and taste disturbance perform similarly to their COVID-naïve baseline, on gold-standard smell and taste tests. STUDY

designProspective cross-sectional study.

settingUniversity of Miami Department of Otolaryngology in Miami, FL between September 2021, and August 2022.

methodsThose previously COVID-19 positive composed the experimental group, those who reported being COVID-naïve composed the control group. Mean total score for the UPSIT Smell Test, and the Burghart Taste Strip test were the primary outcome measures.

results70 adult subjects (35 former COVID-positive, 35 COVID-naïve) were enrolled, with 21 females and 14 males in each group. 87 % of all subjects were white and were almost distributed evenly between Hispanic and non-Hispanic. Mean UPSIT total score for the experimental group was 30.6 (95 % CI 28.9-32.3), mean UPSIT total score for the control group was 31.2 (95 % CI 29.7-32.8). Mean Burghart total score for the experimental group was 11.3 (95 % CI 10.6-12.0), mean Burghart total score for the control group was 10.7 (95 % CI 9.7-11.8). These showed a significant overlap of the 95 % CI of the mean total score between the control group and the experimental group, suggesting no significant difference between the two groups.

conclusionThese results suggest that COVID-19 patients who experience smell and taste disturbance and recover, regain sensory ability similar to their pre-COVID ability. Further study is needed to validate these findings, but the results are promising in the long-term recovery of COVID-19.

Indexed as

COVID-19Olfaction DisordersAdultCross-Sectional StudiesDysgeusiaFemaleHumansMaleProspective StudiesRecovery of FunctionSmell

Identifiers

PMID37738881
PMCPMC12756981

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.